Viatris Inc (VTRS)

↓ Download CSV

CIK 0001792044 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Viatris Inc reported revenue of $14.25B, down 3.0% from the prior year. The company ran a net loss, with a net margin of -24.7% and a gross margin of 35.2%. It held $37.19B in total assets against $22.48B in total liabilities.

Key ratios (FY2025)

35.2%
Gross margin
-18.7%
Operating margin
-24.7%
Net margin
-23.9%
Return on equity
-3.0%
Revenue growth (YoY)
Metric (FY)202520242023202220212020201920182017
Revenue$14.25B$14.69B$15.39B$16.22B$17.81B$11.82B$11.37B$11.27B
Cost of Revenue$9.29B$9.12B$8.99B$9.77B$12.31B$8.15B$7.60B$7.43B
Gross Profit$5.01B$5.62B$6.44B$6.50B$5.58B$3.80B$3.90B$4.00B
Operating Income-$2.66B$10.10M$766.20M$1.61B-$34.00M-$210.80M$715.50M$905.60M
Net Income-$3.51B-$634.20M$54.70M$2.08B-$1.27B-$669.90M$16.80M$352.50M
EPS (Diluted)$-3.00$-0.53$0.05$1.71$-1.05$-1.11$0.03$0.68
Total Assets$37.19B$41.50B$47.69B$50.02B$54.84B$61.55B$31.26B
Total Liabilities$22.48B$22.87B$27.22B$28.95B$34.35B$38.60B$19.37B
Shareholders' Equity$14.71B$18.64B$20.47B$21.07B$20.49B$22.95B$11.88B$12.17B$13.31B
Cash & Equivalents$1.32B$734.80M$991.90M$1.26B$701.20M$844.40M$475.60M$388.10M
Operating Cash Flow$2.32B$2.30B$2.90B$3.00B$3.02B$1.23B$1.80B$2.34B
Capital Expenditures$378.80M$326.00M$377.00M$406.00M$457.20M$243.00M$213.20M$252.10M
Shares Outstanding1.21B1.22B1.21B601.20M516.50M516.50M
Dividends Per Share$0.48$0.48$0.48$0.48$0.33